New CBER Panel Should Be Established For Combo Products Review – AAOS
This article was originally published in The Gray Sheet
Executive Summary
A new FDA advisory panel under the purview of the Center for Biologics Evaluation & Research should be created specifically to review combination products, the American Academy of Orthopaedic Surgeons recommends